Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A patient was identified with an unusual autoimmune syndrome consisting of
systemic lupus erythematosus
and sarcoidosis. Her serum contained extremely high levels of autoantibodies to the
DEK
protooncogene product. The patient's serum was used to clone a dek complementary DNA, which was expressed as a histidine-tagged fusion protein in Escherichia coli. Using affinity-purified recombinant
DEK
protein, anti-
DEK
autoantibodies were found in the patient's serum at a titer of 1:10(6) by enzyme-linked immunosorbent assay (ELISA). Longitudinal studies revealed marked variations in anti-
DEK
autoantibody levels over time. Although it has been suggested that anti-
DEK
autoantibodies are a marker for pauciarticular juvenile rheumatoid arthritis with iridocyclitis, the present data suggest that they may be associated with other disease subsets as well. The quantitative ELISA technique will be useful for defining these subsets further and for examining the relationship between anti-
DEK
titers and disease activity.
...
PMID:Autoantibodies to DEK oncoprotein in a patient with systemic lupus erythematosus and sarcoidosis. 970 52
A human cDNA expression library that was used to investigate the nature of autoantigens recognized by the serum from a patient with
systemic lupus erythematosus
revealed the presence of antibodies directed against two transcriptional regulation protein:
DEK
, a site-specific 45 kD DNA binding protein, likely involved in signal transduction and transcriptional regulation, and a novel 28 kD protein that showed a 94% homology with murine ALY, a nuclear protein that plays a role in regulating the activity of TCRalpha enhancer complex. Whereas autoantibodies directed to epitopes on
DEK
are commonly found in patients with pauciarticular onset juvenile rheumatoid arthritis, autoantibodies against ALY have not been described and their occurrence has led to the cloning of the cDNA sequence of the first member of the human ALY family.
...
PMID:Autoantibodies to transcriptional regulation proteins DEK and ALY in a patient with systemic lupus erythematosus. 995 27
Autoantibodies against the transcriptional
DEK
protein have been considered characteristic of the pauciarticular onset subtype of juvenile rheumatoid arthritis (JRA) associated with iridocyclitis in young girls. In this study we investigated the presence of anti-
DEK
autoantibodies in the sera of 288 patients with
SLE
using a recombinant
DEK
protein as autoantigenic target. Thirty sera (10.4%) were positive against
DEK
protein by immunoblotting. Patients with anti-
DEK
autoantibodies show a lower frequency of cutaneous manifestation, exhibit more frequently certain markers of a chronic inflammatory status like anaemia and positivity for C-reactive protein, as well as a higher frequency of anti-double-stranded DNA autoantibodies. In contrast to JRA patients positive for anti-
DEK
autoantibodies, no association with erosive arthritis nor iridocyclitis were found in
SLE
. In conclusion, our results show that 10.4% of
SLE
patients from our area show antibodies against
DEK
protein, although this feature did not clearly establish a clinical subset of the disease.
...
PMID:Autoantibodies to DEK oncoprotein in systemic lupus erythematosus (SLE). 1069 27